Mereo BioPharma Group (MREO) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

MREO is expected to report earnings to fall 150.00% to 0 cents per share on March 26

Mereo BioPharma Group MREO Stock Earnings Reports

Q4'24

Est.

$0.01

Q3'24

Est.

$-0.02

Q2'24

Missed

by $0.01

Q4'23

Est.

$-0.02

Q2'23

Est.

$-0.02

The last earnings report on November 12 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 1.53M shares outstanding, the current market capitalization sits at 515.08M.

View a ticker or compare two or three

Compare

MREO

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MREO
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MREO (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a company, which engages in therapeutics that aim to improve outcomes for patients with osteogenesis imperfecta, alpha-1 antitrypsin deficiency, hypogonadotropic hypogonadism in obese men, and acute exacerbations of chronic obstructive pulmonary disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Cavendish Place

Phone

+44 3330237300

Employees

Web

https://www.mereobiopharma.com